Peter Alter

Prof, MD, FESC

University of Marburg

Germany

Research Interests

Explore related searches

Professors in Germany

Contact this professor

ORCID

Google Scholar

Academic Page

Articles (14)

Characterization and Mortality Risk of Impaired Left Ventricular Filling in COPD

Article Link

Year:

2024

Expiratory Venous Volume and Arterial Tortuosity are Associated with Disease Severity and Mortality Risk in Patients with COPD: Results from COSYCONET

Article Link

Year:

2024

Differential Impact of Low Fat-Free Mass in People With COPD Based on BMI Classifications

Article Link

Year:

2023

Characteristics of Current Smokers versus Former Smokers with COPD and Their Associations with Smoking Cessation Within 4.5 Years: Results from COSYCONET

Article Link

Year:

2023

Clinical factors linked to the type of respiratory medication in COPD: results from the COSYCONET cohort

Article Link

Year:

2023

Disease Progression and Age as Factors Underlying Multimorbidity in Patients with COPD: Results from COSYCONET

Article Link

Year:

2022

A new approach for the detection of obesity-related airway obstruction in lung-healthy individuals

Article Link

Year:

2022

Basic Determinants of Disease Knowledge in COPD Patients: Results from COSYCONET

Article Link

Year:

2022

Differences in the Measurement of Functional Residual Capacity Between Body Plethysmographs of Two Manufacturers

Article Link

Year:

2022

Impact of the COVID-19 pandemic on the behaviour and health status of patients with COPD: results from the German COPD cohort COSYCONET

Article Link

Year:

2021

Treatment of COPD Groups GOLD A and B with Inhaled Corticosteroids in the COSYCONET Cohort – Determinants and Consequences

Article Link

Year:

2021

<p>Impact of Education on COPD Severity and All-Cause Mortality in Lifetime Never-Smokers and Longtime Ex-Smokers: Results of the COSYCONET Cohort</p>

Article Link

Year:

2020

Update in Chronic Obstructive Pulmonary Disease 2019

Article Link

Year:

2020

<p>A Post Hoc Holter ECG Analysis of Olodaterol and Formoterol in Moderate-to-Very-Severe COPD</p>

Article Link

Year:

2020

Collaborators (4)

Klaus F. Rabe

Professor of Pulmonary Medicine

Christian-Albrechts-Universität zu Kiel

GERMANY

Michael Pienn

AUSTRIA

Felipe V C Machado

Hasselt University

BELGIUM

Stefan Andreas

Head

GERMANY

Peter Alter

Research Interests

Explore related searches

Contact this professor

Articles (14)

Characterization and Mortality Risk of Impaired Left Ventricular Filling in COPD

Expiratory Venous Volume and Arterial Tortuosity are Associated with Disease Severity and Mortality Risk in Patients with COPD: Results from COSYCONET

Differential Impact of Low Fat-Free Mass in People With COPD Based on BMI Classifications

Characteristics of Current Smokers versus Former Smokers with COPD and Their Associations with Smoking Cessation Within 4.5 Years: Results from COSYCONET

Clinical factors linked to the type of respiratory medication in COPD: results from the COSYCONET cohort

Disease Progression and Age as Factors Underlying Multimorbidity in Patients with COPD: Results from COSYCONET

A new approach for the detection of obesity-related airway obstruction in lung-healthy individuals

Basic Determinants of Disease Knowledge in COPD Patients: Results from COSYCONET

Differences in the Measurement of Functional Residual Capacity Between Body Plethysmographs of Two Manufacturers

Impact of the COVID-19 pandemic on the behaviour and health status of patients with COPD: results from the German COPD cohort COSYCONET

Treatment of COPD Groups GOLD A and B with Inhaled Corticosteroids in the COSYCONET Cohort – Determinants and Consequences

<p>Impact of Education on COPD Severity and All-Cause Mortality in Lifetime Never-Smokers and Longtime Ex-Smokers: Results of the COSYCONET Cohort</p>

Update in Chronic Obstructive Pulmonary Disease 2019

<p>A Post Hoc Holter ECG Analysis of Olodaterol and Formoterol in Moderate-to-Very-Severe COPD</p>

Collaborators (4)

Klaus F. Rabe

Michael Pienn

Felipe V C Machado

Stefan Andreas

How do I reach out?

Meet Kite AI